Drug project high-priority medications
WikiDoc Drug Project — High-Priority Medications
- Template here: Drug page template
- Example here: Clopidogrel
- FDA package insert here: DailyMed
List of high-priority medications
Novel Drug Approvals for 2021
Novel Drug Approvals for 2020
Novel Drug Approvals for 2019
No. | Drug Name | Active Ingredient | Approval Date | FDA-approved use on approval date |
---|---|---|---|---|
48 | Ubrelvy | ubrogepant | 12/23/2019 | to treat acute treatment of migraine with or without aura in adults |
47 | Enhertu | fam-trastuzumab deruxtecan-nxki | 12/20/2019 | To treat metastatic breast cancer |
46 | Dayvigo | lemborexant | 12/20/2019 | To treat insomnia |
45 | Caplyta | lumateperone tosylate | 12/20/2019 | To treat schizophrenia |
44 | TissueBlue | Brilliant Blue G Ophthalmic Solution | 12/20/2019 | Dye used in eye surgery |
43 | Padcev | enfortumab vedotin-ejfv | 12/18/2019 | To treat refractory bladder cancer |
42 | Vyondys 53 | golodirsen | 12/12/2019 | To treat certain patients with Duchenne muscular dystrophy |
41 | Oxbryta | voxelotor | 11/25/2019 | To treat sickle cell disease |
40 | Xcopri | cenobamate | 11/21/2019 | To treat partial onset seizures |
39 | Givlaari | givosiran | 11/20/2019 | To treat acute hepatic porphyria, a rare blood disorder |
38 | Adakveo | crizanlizumab-tmca | 11/15/2019 | To treat patients with painful complication of sickle cell disease |
37 | Fetroja | cefiderocol | 11/14/2019 | To treat patients with complicated urinary tract infections who have limited or no alternative treatment options |
36 | Brukinsa | zanubrutinib | 11/14/2019 | To treat certain patients with mantle cell lymphoma, a form of blood cancer |
35 | Reblozyl | luspatercept–aamt | 11/8/2019 | For the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell transfusions |
34 | ExEm Foam | air polymer-type A | 11/7/2019 | A diagnostic agent used to assess fallopian tube patency (openness) in women with known or suspected infertility |
33 | Trikafta | elexacaftor/ivacaftor/tezacaftor | 10/21/2019 | To treat patients 12 years of age and older with the most common gene mutation that causes cystic fibrosis |
32 | Reyvow | lasmiditan | 10/11/2019 | For the acute treatment of migraine with or without aura, in adults |
31 | fluorodopa F 18 | 10/10/2019 | A diagnostic agent for use in positron emission tomography (PET) to help diagnose adult patients with suspected Parkinsonian syndromes (PS) | |
30 | Scenesse | afamelanotide | 10/8/2019 | To increase pain-free light exposure in adult patients with a history of phototoxic reactions (damage to skin) from erythropoietic protoporphyria |
29 | Beovu | brolucizumab–dbll | 10/7/2019 | Treatment of wet age-related macular degeneration |
28 | Aklief | trifarotene | 10/4/2019 | For the topical treatment of acne vulgaris in patients 9 years of age and older |
27 | Ibsrela | tenapanor | 9/12/2019 | To treat irritable bowel syndrome with constipation in adults. |
26 | Nourianz | istradefylline | 8/27/2019 | To treat adult patients with Parkinson’s disease experiencing “off” episodes |
25 | Ga-68-DOTATOC | Ga-68-DOTATOC | 8/21/2019 | For use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) |
24 | Xenleta | lefamulin | 8/19/2019 | To treat adults with community-acquired bacterial pneumonia |
23 | Rinvoq | upadacitinib | 8/16/2019 | To treat adults with moderately to severely active rheumatoid arthritis |
22 | Inrebic | fedratinib | 8/16/2019 | To treat adult patients with intermediate-2 or high-risk primary or secondary myelofibrosis |
21 | Rozlytrek | entrectinib | 8/15/2019 | To treat adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive |
20 | Wakix | pitolisant | 8/14/2019 | To treat excessive daytime sleepiness (EDS) in adult patients with narcolepsy |
19 | pretomanid | 8/14/2019 | For treatment-resistant forms of tuberculosis that affects the lungs | |
18 | Turalio | pexidartinib | 8/2/2019 | To treat adult patients with symptomatic tenosynovial giant cell tumor |
17 | Nubeqa | darolutamide | 7/30/2019 | To treat adult patients with non-metastatic castration resistant prostate cancer |
16 | Accrufer | ferric maltol | 7/25/2019 | To treat iron deficiency anemia in adults |
15 | Recarbrio | imipenem, cilastatin and relebactam | 7/16/2019 | To treat complicated urinary tract and complicated intra-abdominal infections |
14 | Xpovio | selinexor | 7/3/2019 | To treat adult patients with relapsed or refractory multiple myeloma (RRMM) |
13 | Vyleesi | bremelanotide | 6/21/2018 | To treat hypoactive sexual desire disorder in premenopausal women. |
12 | Polivy | polatuzumab vedotin-piiq | 6/10/2019 | To treat adult patients with relapsed or refractory diffuse large B-cell lymphoma |
11 | Piqray | alpelisib | 5/24/2019 | To treat breast cancer |
10 | Vyndaqel | tafamidis meglumine | 5/3/2019 | To treat heart disease (cardiomyopathy) caused by transthyretin mediated amyloidosis (ATTR-CM) in adults |
9 | Skyrizi | risankizumab-rzaa | 4/23/2019 | To treat moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy |
8 | Balversa | erdafitinib | 4/12/2019 | To treat adult patients with locally advanced or metastatic bladder cancer |
7 | Evenity | romosozumab-aqqg | 4/9/2019 | To treat osteoporosis in postmenopausal women at high risk of fracture |
6 | Mayzent | siponimod | 3/26/2019 | To treat adults with relapsing forms of multiple sclerosis |
5 | Sunosi | solriamfetol | 3/20/2019 | To treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea |
4 | Zulresso | brexanolone | 3/19/2019 | To treat postpartum depression (PPD) in adult women |
3 | Egaten | triclabendazole | 2/13/2019 | To treat fascioliasis, a parasitic infestation caused by two species of flatworms or trematodes that mainly the affect the liver, sometimes referred to as “liver flukes” |
2 | Cablivi | caplacizumab-yhdp | 2/6/2019 | To treat adult patients with acquired thrombotic thrombocytopenic purpura (aTTP) |
1 | Jeuveau | prabotulinumtoxinA-xvfs | 2/1/2019 | For the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients |
Year | No. | Brand Name | Active Ingredient | Page Link | DailyMed Search | Approval Date | Status | Author |
2019 | 12 | Polivy | Polatuzumab vedotin-piiq | Polatuzumab vedotin-piiq | Polivy | 6/10/2019 | ||
2019 | 11 | Piqray | Alpelisib | Alpelisib | Piqray | 5/24/2019 | Needs review | Uma Maveli |
2019 | 10 | Vyndaqel | Tafamidis meglumine | Tafamidis meglumine | Vyndaqel | 5/3/2019 | ||
2019 | 9 | Skyrizi | Risankizumab | Risankizumab | Skyrizi | 4/23/2019 | ||
2019 | 8 | Balversa | Erdafitinib | Erdafitinib | Balversa | 4/12/2019 | ||
2019 | 7 | Evenity | Romosozumab | Romosozumab | Evenity | 4/9/2019 | ||
2019 | 6 | Mayzent | Siponimod | Siponimod | Mayzent | 3/26/2019 | ||
2019 | 5 | Sunosi | Solriamfetol | Solriamfetol | Sunosi | 3/20/2019 | ||
2019 | 4 | Zulresso | Brexanolone | Brexanolone | Zulresso | 3/19/2019 | ||
2019 | 3 | Egaten | Triclabendazole | Triclabendazole | Egaten | 2/13/2019 | ||
2019 | 2 | Cablivi | Caplacizumab | Caplacizumab | Cablivi | 2/6/2019 | ||
2019 | 1 | Jeuveau | prabotulinum toxin type a powder | prabotulinum toxin type a powder | Jeuveau | 2/1/2019 | ||
2018 | 59 | Ultomiris | Ravulizumab | Ravulizumab | Ultomiris | 12/21/2018 | Needs review | Bhavya |
2018 | 58 | Elzonris | Tagraxofusp-erzs | Tagraxofusp-erzs | Elzonris | 12/21/2018 | ||
2018 | 57 | Asparlas | Calaspargase pegol-mknl | Calaspargase pegol-mknl | Asparlas | 12/20/2018 | ||
2018 | 56 | Motegrity | Prucalopride | Prucalopride | Motegrity | 12/14/2018 | ||
2018 | 55 | Xospata | Gilteritinib | Gilteritinib | Xospata | 11/28/2018 | Needs review | Uma Maveli |
2018 | 54 | Firdapse | Amifampridine | Amifampridine | Firdapse | 11/28/2028 | ||
2018 | 53 | Vitrakvi | Larotrectinib | Larotrectinib | Vitrakvi | 11/26/2018 | ||
2018 | 52 | Daurismo | Glasdegib | Glasdegib | Daurismo | 11/21/2018 | Need review | Bhavya |
2018 | 51 | Gamifant | Emapalumab-lzsgemapalumab-lzsg | Emapalumab-lzsgemapalumab-lzsg | Gamifant | 11/20/2018 | ||
2018 | 50 | Aemcolo | Rifamycin | Rifamycin | Aemcolo | 11/16/2018 | ||
2018 | 49 | Yupelri | Revefenacin | Revefenacin | Yupelri | 11/9/2018 | Needs review | Uma Maveli |
2018 | 48 | Lorbrena | Lorlatinib | Lorlatinib | Lorbrena | 11/2/2018 | Needs review | Uma Maveli |
2018 | 47 | Xofluza | Baloxavir marboxil | Baloxavir marboxil | Xofluza | 10/24/2018 | ||
2018 | 46 | Talzenna | Talazoparib | Talazoparib | Talzenna | 10/16/2018 | ||
2018 | 45 | Tegsedi | Inotersen | Inotersen | Tegsedi | 10/5/2018 | ||
2018 | 44 | Revcovi | Elapegademase-lvlr | Elapegademase-lvlr | Revcovi | 10/5/2018 | ||
2018 | 43 | Nuzyra | Omadacycline | Omadacycline | Nuzyra | 10/2/2018 | ||
2018 | 42 | Seysara | Sarecycline | Sarecycline | Seysara | 10/1/2018 | ||
2018 | 41 | Libtayo | Cemiplimab-rwlc | Cemiplimab-rwlc | Libtayo | 9/28/2018 | ||
2018 | 40 | Vizimpro | Dacomitinib | Dacomitinib | Vizimpro | 9/27/2018 | ||
2018 | 39 | Emgality | Galcanezumab-gnlm | Galcanezumab-gnlm | Emgality | 9/27/2018 | ||
2018 | 38 | Copiktra | Duvelisib | Duvelisib | Copiktra | 9/24/2018 | ||
2018 | 37 | Ajovy | Fremanezumab-vfrm | Fremanezumab-vfrm | Ajovy | 9/14/2018 | ||
2018 | 36 | Lumoxiti | Moxetumomab pasudotox-tdfk | Moxetumomab pasudotox-tdfk | Lumoxiti | 9/13/2018 | ||
2018 | 35 | Pifeltro | Doravirine | Doravirine | Pifeltro | 8/30/2018 | ||
2018 | 34 | Xerava | Eravacycline | Eravacycline | Xerava | 8/27/2018 | ||
2018 | 33 | Takhzyro | Lanadelumab | Lanadelumab | Takhzyro | 8/23/2018 | ||
2018 | 32 | Oxervate | Cenegermin-bkbj | Cenegermin-bkbj | Oxervate | 8/22/2018 | ||
2018 | 31 | Diacomit | Stiripentol | Stiripentol | Diacomit | 8/20/2018 | ||
2018 | 30 | Galafold | Migalastat | Migalastat | Galafold | 8/10/2018 | ||
2018 | 29 | Annovera | Segesterone acetate and ethinyl estradiol vaginal system | Segesterone acetate and ethinyl estradiol vaginal system | Annovera | 8/10/2018 | ||
2018 | 28 | Onpattro | Patisiran | Patisiran | Onpattro | 8/10/2018 | ||
2018 | 27 | Poteligeo | Mogamulizumab | Mogamulizumab | Poteligeo | 8/8/2018 | ||
2018 | 26 | Mulpleta | Lusutrombopag | Lusutrombopag | Mulpleta | 7/31/2018 | ||
2018 | 25 | Omegaven | Fish oil triglycerides | Fish oil triglycerides | Omegaven | 7/27/2018 | Bhavya | In progress |
2018 | 24 | Orilissa | Elagolix | Elagolix | Orilissa | 7/23/2018 | ||
2018 | 23 | Krintafel | Tafenoquine | Tafenoquine | Krintafel | 7/20/2018 | ||
2018 | 22 | Tibsovo | Ivosidenib | Ivosidenib | Tibsovo | 7/20/2018 | ||
2018 | 21 | TPOXX | Tecovirimat | Tecovirimat | TPOXX | 7/13/2018 | ||
2018 | 20 | Braftovi | Encorafenib | Encorafenib | Braftovi | 6/27/2018 | ||
2018 | 19 | Mektovi | Binimetinib | Binimetinib | Mektovi | 6/27/2018 | ||
2018 | 18 | Zemdri | Plazomicin | Plazomicin | Zemdri | 6/25/2018 | ||
2018 | 17 | Epidioloex | Cannabidiol | Cannabidiol | Epidioloex | 6/25/2018 | ||
2018 | 16 | Moxidectin | Moxidectin | Moxidectin | Moxidectin | 6/13/2018 | ||
2018 | 15 | Olumiant | Baricitinib | Baricitinib | Olumiant | 5/31/2018 | ||
2018 | 14 | Palynziq | Pegvaliase-pqpz | Pegvaliase-pqpz | Palynziq | 5/24/2018 | ||
2018 | 13 | Doptelet | Avatrombopag | Avatrombopag | Doptelet | 5/21/2018 | ||
2018 | 12 | Lokelma | Sodium zirconium cyclosilicate | Sodium zirconium cyclosilicate | Lokelma | 5/18/2018 | ||
2018 | 11 | Aimovig | Erenumab-aooe | Erenumab-aooe | Aimovig | 5/17/2018 | ||
2018 | 10 | Lucemyra | Lofexidine hydrochloride | Lofexidine hydrochloride | Lucemyra | 5/16/2018 | ||
2018 | 9 | Akynzeo | Fosnetupitant and palonosetron | Fosnetupitant and palonosetron | Akynzeo | 4/19/2018 | ||
2018 | 8 | Crysvita | Burosumab-twza | Burosumab-twza | Crysvita | 4/17/2018 | ||
2018 | 7 | Tavalisse | Fostamatinib | Fostamatinib | Tavalisse | 4/17/2018 | ||
2018 | 6 | Ilumya | Tildrakizumab | Tildrakizumab | Ilumya | 3/20/2018 | ||
2018 | 5 | Trogarzo | Ibalizumab-uiyk | Ibalizumab-uiyk | Trogarzo | 3/6/2018 | ||
2018 | 4 | Erleada | Apalutamide | Apalutamide | Erleada | 2/14/2018 | ||
2018 | 3 | Symdeko | Tezacaftor/ivacaftor | Tezacaftor/ivacaftor | Symdeko | 2/12/2018 | ||
2018 | 2 | Biktarvy | Bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate | Bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate | Biktarvy | 2/7/2018 | ||
2018 | 1 | Lutathera | Lutetium lu 177 dotatate | Lutetium lu 177 dotatate | Lutathera | 1/26/2018 |